Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIMIT Trial: Lidocaine with Benzathine Penicillin G for Syphilis
NCT06391125Phase 3Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Jul 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine in syphilis (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Mean Pain Score of Injection at 10 minutes. Started Jul 2024; status: recruiting.
02
Drugs
lidocaine
03
Conditions
syphilis
Beyond the preview
Go deeper on NCT06391125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06391125.